Yale Cancer Center Experts Set to Present Advances in Cancer Research at the World’s Largest Clinical Oncology Conference

Yale Cancer Center Experts Set to Present Advances in Cancer Research at the World’s Largest Clinical Oncology Conference

Over 40 Yale Cancer Center (YCC) physicians and scientists will present new research at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from May 30 to June 3. This is the largest and most attended conference for oncology professionals, who are interested in learning about the latest, practice-changing cancer research.

Breast Cancer Experts Bookmark Top Abstracts to Watch at the 2025 ASCO Annual Meeting

To prepare for the 2025 ASCO Annual Meeting, breast cancer experts share the abstracts and discussions they’re most excited to see at the meeting.

T-DXd Regimen Improves pCR in Early HER2+ Breast Cancer

T-DXd followed by THP improved pCR in high-risk, early-stage HER2+ breast cancer in the phase 3 DESTINY-Breast11 trial.

Recent ADC Approvals and Their Impact on the Breast Cancer Space

Neil M. Iyengar, MD, highlighted the recent T-DXd and Dato-DXd approvals in breast cancer.